← Back to Search

Behavioral Intervention

WISER for Burnout

N/A
Recruiting
Led By John B Sexton, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 8, and 1, 6, and 12 month follow-ups
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if online activities that encourage positive thinking or actions can help adults who are stressed, depressed, or burned out feel better. Participants will do these activities and complete surveys to see if their well-being improves.

Who is the study for?
The WISER Study is for adults over 18, including healthcare workers from Duke University Health System and other health systems. It's aimed at those interested in using web-based tools to build resilience against stress, depression, and burnout.
What is being tested?
This study tests if online positive psychology tools can improve well-being by having participants engage in activities like writing gratitude letters. The effects are measured through surveys before, after, and up to 12 months post-use.
What are the potential side effects?
Risks are minimal but may include emotional or psychological distress when answering questions about personal experiences with burnout during the survey process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 8, and 1, 6, and 12 month follow-ups
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 8, and 1, 6, and 12 month follow-ups for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Emotional Exhaustion as measured by the 5-item Emotional Exhaustion Scale
Secondary study objectives
Change in Emotional Recovery as measured by the 4-item Emotional Recovery Scale
Change in Work-life Integration as measured by the 7-item Work-life Integration Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment ImmediatelyExperimental Treatment1 Intervention
Participants will engage in well-being tools immediately for 1-week.
Group II: Waitlist ControlActive Control1 Intervention
Participants will wait 1 week to begin the well-being tools.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for burnout include cognitive behavioral therapy (CBT), mindfulness-based interventions, and positive psychology interventions. These treatments work by altering negative thought patterns, reducing stress, and enhancing emotional resilience. Positive psychology interventions, such as gratitude exercises and reflecting on positive experiences, aim to shift focus from stressors to positive aspects of life, thereby improving overall well-being. For burnout patients, these mechanisms are crucial as they help in managing stress, improving mood, and fostering a sense of control and accomplishment, which are often diminished in burnout.
Evidence-based psychosocial treatments for children and adolescents exposed to traumatic events.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,455 Previous Clinical Trials
2,963,552 Total Patients Enrolled
John B Sexton, PhDPrincipal InvestigatorDuke

Media Library

WISER (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05636072 — N/A
Burnout Research Study Groups: Treatment Immediately, Waitlist Control
Burnout Clinical Trial 2023: WISER Highlights & Side Effects. Trial Name: NCT05636072 — N/A
WISER (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05636072 — N/A
~2811 spots leftby Dec 2025